Screener
AbbVie ABBV EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
Plus components not separately reported this period.
The source filing: AbbVie’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:51 AM EDT
- Accession
- 0001551152-26-000023
FAQ
- What is AbbVie's EBIT?
- AbbVie (ABBV) reported EBIT of $6.43B in Q2 2026.
- How has AbbVie's EBIT changed year-over-year?
- AbbVie's EBIT increased by 31.4% year-over-year, from $4.89B to $6.43B.
- What is the long-term trend for AbbVie's EBIT?
- Over 3 years (2021 to 2025), AbbVie's EBIT has grown at a -5.6% compound annual growth rate (CAGR), from $17.92B to $15.08B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about AbbVie's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude